Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine for secondary prevention after ischemic stroke
ChiCTR-PRC-09000494Phase 4Completed
- Sponsor
- Shenzhen People's Hospital
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke comparing Berberine treatment arm with Placebo control arm (2 arms). Primary endpoints: Rate of cardiovascular events, Incidence of peripheral arterial disease events and 1 more. Started Oct 2009; status: completed.
02
Drugs
berberine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-PRC-09000494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-09000494.